Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade. - Wikidata - wikimedia - TriplyDB

Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.

Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.

http://www.wikidata.org/entity/Q30981990

about

Testosterone promotes vascular endothelial cell migration via upregulation of ROCK-2/moesin cascade Novel Insights into the Roles of Rho Kinase in Cancer Regulation of ROCK activity in cancer Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancer Induction of cell cycle arrest by increasing GTP‑RhoA levels via Taxol‑induced microtubule polymerization in renal cell carcinoma.Rho/ROCK signaling in motility and metastasis of gastric cancer Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion A proteomic study of potential VEGF-C-associated proteins in bladder cancer T24 cells Vascular endothelial growth factor C promotes breast cancer progression via a novel antioxidant mechanism that involves regulation of superoxide dismutase 3.Proteomic analysis of proton beam irradiated human melanoma cells Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies.Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance.The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it.The indolinone MAZ51 induces cell rounding and G2/M cell cycle arrest in glioma cells without the inhibition of VEGFR-3 phosphorylation: involvement of the RhoA and Akt/GSK3β signaling pathways Targets of miR-200c mediate suppression of cell motility and anoikis resistance Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.Lymphangiogenesis in cervical cancer evaluated by expression of the VEGF-C gene in clinical stage IB-IIIB.Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits.BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.Expression and significances of contactin-1 in human gastric cancer.The non-canonical role of vascular endothelial growth factor-C axis in cancer progression Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.The ezrin-radixin-moesin family of proteins in the regulation of B-cell immune response.Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein.Vascular endothelial growth factor C enhances cervical cancer migration and invasion via activation of focal adhesion kinase.Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers.Inhibition of rho-kinase by fasudil suppresses formation and progression of experimental abdominal aortic aneurysms Quantum dots (QDs) restrain human cervical carcinoma HeLa cell proliferation through inhibition of the ROCK-c-Myc signaling.Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.

P2860

Q24337249-0E9C608C-30AD-4752-A1CC-174318C405D6 Q26771368-B18BFBD3-FBED-4400-920B-36FA83F386D7 Q27006554-8838FECB-E25D-427E-A7D3-AE1CF7145239 Q31172479-5F62F6E2-843F-4F6C-B903-C58C0D51FF99 Q33702248-3197F37B-131F-441B-9B26-AC84E64D3EA4 Q34326599-5909D3AB-966F-4F97-91A8-62A281F83E00 Q34332451-A1DC71E7-E1FD-4F79-8AA1-BD70AD680F9E Q34461897-E7F32AD9-B170-442D-AB6D-8C495C6C35C2 Q35000353-38C710AB-CA9D-4F1A-A315-939F67195B53 Q35083440-D305F030-501C-4D5C-85A4-C37EDE15E477 Q35113402-783DF457-E4E9-49EA-A687-886D64D7419C Q35142784-F0FEFF26-9DEC-4308-BFFD-FD14EB64670C Q35223554-0FD632C3-57F2-4BCA-828E-74E29E2B6C00 Q35287066-678E9EF4-25A3-4413-B7E1-2EFC44F94D2E Q35559037-D384755E-1D7E-4057-8938-DF1EA84BD6FF Q35684987-B945C9AD-A4D2-4044-9750-B9BB5F0AAA18 Q35837013-6DE16006-E070-4A1F-8405-F07001239948 Q36265146-6B5A31E6-BA86-42ED-AC01-341ED53E07CE Q36502747-DD4E8035-522B-40FF-9EB6-67BA895FC786 Q36550104-D5E50FA7-A878-42C2-AF55-326FFF61F126 Q36766051-30401BB7-5012-497C-8D42-1692A99AFAB5 Q37071029-2A77EECE-1544-45B0-99E4-155BD87CC396 Q37687460-ECE79AC2-5E25-4517-812C-3BD95805716A Q38368921-573BB10C-39CA-4A23-BC4E-38D323F95EE5 Q38957389-E43F66D3-428C-4B72-838C-0F25642991C8 Q39013546-52B8CA28-7734-469B-91EB-EB4AA190AE4F Q39311151-81D58952-15E3-4E90-A380-8EFFE5A8BBC6 Q39408668-DED891F9-C4D7-49D9-AEE2-2932AB9D8C00 Q41871593-8F6F9D09-9CF8-40FF-A8E3-2E872D7980AC Q41994097-59B34A04-F273-4CFA-BD36-16302614184D Q46918671-4F791352-4735-4325-9804-F3F5DE879685 Q47761327-7C158892-C035-4405-9054-0173527108CF

P2860

Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.

http://www.wikidata.org/entity/Q30981990

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade.

@ast

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade.

@en

type

label

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade.

@ast

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade.

@en

prefLabel

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade.

@ast

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade.

@en

P1433

Q30981990-93E95AB4-1398-4B74-AECF-FE2063E75C62

P1476

Q30981990-93D96168-9209-4F10-8838-9B40DD3C5E14

P2093

Q30981990-14C1CD09-4FBE-48CF-8545-6CCD35F5B69C

Q30981990-3D04DCD8-789E-4866-982C-6CF11E8394DC

Q30981990-5C83C0D2-D4AB-4CFF-A2F7-9D02C4BB3143

Q30981990-B85256EF-63DE-4AB9-AE5E-FFE732FD2F12

Q30981990-D83E92CE-1D51-40E2-9EB2-BD905599467A

Q30981990-F728D054-403C-4855-96DE-98D101BDC697

P2860

Q30981990-08F99FC7-E59E-4F0B-8833-F5773C645BEB

Q30981990-12563B3C-65AF-4570-B9BE-FF562332CC1F

Q30981990-17F6FFF7-EF26-4F17-AEFF-FB1DC350414B

Q30981990-1A5B08BA-4B00-4EA2-BB52-3D5837EFE1C1

Q30981990-1D1EBB07-28CA-4810-8106-39AFE1924E3E

Q30981990-27D27E80-64E4-4A08-B70A-03C27294DD11

Q30981990-27F36125-F94A-44FC-A690-4C7632377D33

Q30981990-320BB9C5-568C-4DD5-A768-CC1D8814EA81

Q30981990-3D93F4B6-0AF6-44EF-816E-94C5056FBBBB

Q30981990-3F8B29E1-5C02-4196-92D2-04A05DFF1535

P2888

Q30981990-6FBBE5A0-DE2D-4A02-BC7D-9CEA3A8C1F94

P304

Q30981990-34683119-DA19-449C-9490-A06B64D9B8E0

P31

Q30981990-29BAD632-A40A-4B01-879C-E04AE8065BE8

P356

Q30981990-E4D085BC-4357-4A3B-90A5-0B7EDD2CF470

P407

Q30981990-60281C52-6907-404E-83B7-E3FBF899EE72

P478

Q30981990-40D85F29-B861-4C1C-B88F-87CDA09AD1F6

P50

Q30981990-EA71DCD6-1692-4A2A-A362-C541B2909DD0

P577

Q30981990-6F72AA6C-987C-4FF0-8572-55FBE0F23013

P5875

Q30981990-C23B76E9-B3BB-431B-A417-61DBAEE14755

P6179

Q30981990-9AD1A6CF-1F0A-4267-8DB4-7144BF353257

P698

Q30981990-13E56563-D441-4455-90A0-293D17A2D8ED

P921

Q30981990-F7E551F5-D25D-4AEE-BC81-ED0E207702F6

P932

Q30981990-5CBCE2D1-6E32-4E83-B1C9-89A1C3313AD6

P356

1471-2407-10-170

P1433

P1476

Vascular endothelial growth fa ...... of RhoA/ROCK-2/moesin cascade

@en

P2093

Jinghe Huang

http://www.w3.org/2001/XMLSchema#string

Junxiu Liu

http://www.w3.org/2001/XMLSchema#string

Mian He

http://www.w3.org/2001/XMLSchema#string

Qiongshan Liu

http://www.w3.org/2001/XMLSchema#string

Wen Li

http://www.w3.org/2001/XMLSchema#string

Yang Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

Prophylactic human papillomavirus vaccines

Cellular motility driven by assembly and disassembly of actin filaments

The biology of VEGF and its receptors

Conformational activation of radixin by G13 protein alpha subunit

VEGF-C mediates cyclic pressure-induced endothelial cell proliferation

Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas

Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase

The biology of vascular endothelial growth factor

P2888

1471-2407-10-170

P304

170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-10-170

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43353874

http://www.w3.org/2001/XMLSchema#string

P6179

1030142977

http://www.w3.org/2001/XMLSchema#string

P698

20429915

http://www.w3.org/2001/XMLSchema#string

P921

P932

2873393

http://www.w3.org/2001/XMLSchema#string